My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
SITE INFORMATION AND CORRESPONDENCE_1985-1997
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
P
>
PACIFIC
>
5400
>
2900 - Site Mitigation Program
>
PR0522692
>
SITE INFORMATION AND CORRESPONDENCE_1985-1997
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/2/2020 2:47:19 PM
Creation date
4/2/2020 2:16:02 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
SITE INFORMATION AND CORRESPONDENCE
FileName_PostFix
1985-1997
RECORD_ID
PR0522692
PE
2957
FACILITY_ID
FA0015465
FACILITY_NAME
FORMER MONTGOMERY WARDS AUTO SRV CTR
STREET_NUMBER
5400
STREET_NAME
PACIFIC
STREET_TYPE
AVE
City
STOCKTON
Zip
95207
APN
10227008
CURRENT_STATUS
01
SITE_LOCATION
5400 PACIFIC AVE
P_LOCATION
01
P_DISTRICT
002
QC Status
Approved
Scanner
SJGOV\sballwahn
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
401
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
REGENESIS 27130A Paseo Espada,Suite 1407 <br /> Bioremediation Products San Juan Capistrano,CA 92675 <br /> Phone: (714)443-3136 <br /> Fax: (714)443-3140 <br /> The Company and Its Products <br /> Introduction <br /> REGENESIS was incorporated in the Spring of 1994 to continue the development <br /> and commercialization of Oxygen Release Compound, ORC". ORC is a patented_ <br /> formulation of a very fine, insoluble solid peroxygen which has been formulated to release <br /> oxygen at a controlled rate when hydrated. Since oxygen is frequently the limiting factor <br /> in bioremediation, the product has been demonstrated to increase the remediation of <br /> hydrocarbon contamination in soil and groundwater. The company is now in the <br /> commercialization stage, working with clients to meet their specific project needs. <br /> The Company <br /> The roots of the company go back several years before its incorporation in California. The <br /> inventors originally began working on a similar product used to facilitate the growth of <br /> plants in oxygen poor soils. That product, OXYGEN PLUS®, is now sold to the horticultural <br /> market. <br /> Formulations of ORC, more appropriate to bioremediation applications, were first tested <br /> in the laboratory over three years ago. After several successful laboratory results and <br /> small scale field tests, the company commissioned Arthur D. Little to complete a market <br /> study. This September 1993 study indicated a significant commercial opportunity. <br /> Concurrent with the study and encouraged by its results, REGENESIS decided to conduct <br /> several full scale field demonstrations. One of the most significant was published in a <br /> Ground Water Monitoring and Remediation article (Winter 1994) which describes the <br /> results of an application of ORC by the University of Waterloo at the widely studied Borden <br /> Aquifer. <br /> The Founder and Chairman of the Board of REGENESIS is Mr. Gavin S. Herbert, who also <br /> founded Allergan Pharmaceuticals—a Fortune 300 company with almost $1 billion is sales. <br /> The President and CEO of the company is Mr. John B. Griffiths, who came to the company <br /> after 15 years in the oil equipment industry. Mr. Griffiths was Vice President and Group <br /> Manager of FMCs $350 million petroleum equipment business and later became President <br /> of Hydril. The co-inventor of the product, Dr. Stephen Koenigsberg is the company's Vice <br /> President of Research. The Scientific Advisory Board is headed by Dr. Herb Ward, <br /> Chairman Emeritus of the Department of Environmental Science and Engineering at Rice <br /> University. He and the other four members are renown scientists in the environmental <br /> remediation industry. REGENESIS' Board of Directors is composed of recognized leaders <br /> from industry and government. <br /> ORC Features and Benefits <br /> The core technology involves a patented formulation which when hydrated releases <br /> oxygen slowly, from a period of a few months to in excess of one year. Regenesis is <br /> working almost exclusively with magnesium peroxide although the patent covers the use <br /> of several other peroxygen materials as a basis for formulating ORC. ORC is <br />
The URL can be used to link to this page
Your browser does not support the video tag.